Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,668 JPY | 0.00% | +1.43% | +12.55% |
May. 02 | BridgeBio Pharma Shares Decline After Q1 Financial Results | MT |
Apr. 08 | U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease | RE |
ETFs positioned on Kyowa Kirin Co. Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.22% | 15 M€ | +11.75% | ||
0.44% | 11 M€ | +13.64% | - | |
0.41% | 251 M€ | +13.17% | ||
0.39% | 31,732 M€ | +15.18% | - | |
0.39% | 1,198 M€ | +14.37% | - | |
0.36% | 67,864 M€ | +15.20% | ||
0.36% | 16,729 M€ | +14.33% | - | |
0.30% | 26 M€ | +21.71% | ||
0.27% | 4 M€ | +16.67% | ||
0.27% | 81 M€ | +15.99% | ||
0.26% | 73 M€ | +18.87% | ||
0.23% | 60 M€ | +16.25% | ||
0.17% | 5,115 M€ | +16.14% | ||
0.17% | 10,207 M€ | +16.36% | ||
0.15% | 18 M€ | +16.15% | - | |
0.15% | 5 M€ | +10.09% | - | |
0.15% | 14 M€ | +5.66% | - | |
0.15% | 14 M€ | +18.73% | ||
0.13% | 20,721 M€ | +15.40% | - | |
0.13% | 144,586 M€ | +16.55% | ||
0.13% | 66,066 M€ | +16.86% | - | |
0.12% | 29 M€ | +8.37% | - | |
0.10% | 469 M€ | -2.05% | - | |
0.10% | 3,859 M€ | +18.82% | - | |
0.09% | 4 M€ | -.--% | - | |
0.03% | 7 M€ | +0.11% | - | |
0.03% | 10 M€ | -3.35% | - | |
0.03% | 7 M€ | +3.48% | - | |
0.02% | 277 M€ | -.--% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.55% | 9.3B | |
+5.48% | 71.19B | |
-13.75% | 5.01B | |
+42.38% | 4.47B | |
+4.51% | 3.96B | |
+21.10% | 2.44B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B | |
+6.53% | 1.69B |
- Stock Market
- Equities
- 4151 Stock
- Funds and ETFs Kyowa Kirin Co. Ltd.